[1]
Khade Shubham Ramchandra and Dr.Pallavi M. Patil 2022. A Molecular Docking Study of Peramivir and Zanamivir as Potential Inhibitors of the H1N1 Influenza Target Protein. International Journal of Pharma and Bio Sciences. 13, 1 (Mar. 2022), 73–79. DOI:https://doi.org/10.22376/ijpbs.2022.13.1.P73-79.